Director, KAT6i (Prifetrastat) Launch Lead, US Breast Cancer
Pfizer - 2 Locations
Posted Nov 16, 2026
Benefits
- Parental leave
- 12 weeks From the posting source
- Non-birth-parent leave
- 12 weeks From the posting source
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Source-linked checked May 7, 2026
- Salary
- $177K-$294K From the posting source
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Staff Plus From the posting source
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, KAT6i (Prifetrastat) Launch Lead, US Breast Cancer 2 Locations ROLE SUMMARY Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery. Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you-across teams, roles, and the Pfizer enterprise. Join us to make history - for patients, for their families, for the future. Prifetrastat is Pfizer's first-in-class oral KAT6 inhibitor, in development with fulvestrant for adults with previously treated HR+/HER2- metastatic breast cancer (BC). Prifetrastat is the next wave of Pfizer's breast cancer portfolio and a chance to launch a new mechanism of action in a crowded post-CDK4/6 inhibitor landscape. This role leads US launch readiness for prifetrastat. You will own one integrated launch plan across the brand team, market development, access, and operations, and drive the cross-functional team to every milestone from pre-launch through approval and first patient. You will work in step with the Global Launch Team so the US plan reflects global strategy and US realities, and you will collaborate closely with Commercial, Medical, Legal, Regulatory, Market Access, Supply, Sales,
Read the full description at pfizer.wd1.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Director, Team Lead, KAT6i (Prifetrastat), US Breast Cancer
Pfizer - 2 Locations
Commercial Lead Oncology Baltics
Ipsen - Vilnius
Director, Global Oncology Publications
AstraZeneca - US - Boston - MA
Associate Director, Launch Excellence
Revolution Medicines - Remote (United States)